LBP14-G4 S-N6

General Information


DRACP ID  DRACP04119

Peptide Name   LBP14-G4 S-N6

Sequence  RVQGRWKVRASFFKGGGGSGFAWNVCVYRNGVRVCHRRAN

Sequence Length  40

UniProt ID  A0A3F2YLM5 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  6K4V 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C200H309N71O48S2

Absent amino acids  DEILMPT

Common amino acids  GR

Mass  523602

Pl  12.39

Basic residues  10

Acidic residues  0

Hydrophobic residues  14

Net charge  10

Boman Index  -10019

Hydrophobicity  -50

Aliphatic Index  51

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  12615

Absorbance 280nm  323.46

Polar residues  15

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31974490

Title  Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17276

DRACP is developed by Dr.Zheng's team.